Publications by authors named "Giuseppe Console"

Claim this Profile
C
Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation.
Massimo Martino, Mercedes Gori, Gaetana Porto, Maria Pellicano, Ludovica Santoro, Giuseppe Console

Ann Hematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation.
Massimo Martino, Mercedes Gori, Gaetana Porto, Maria Pellicano, Ludovica Santoro, Giuseppe Console

Ann Hematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic.
Filippo A Canale, Massimo Martino, Gaetana Porto, Chiara Verduci, Giuseppe Console

Support Care Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide.
Jacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, Samia Harbi, Francesca Patriarca, Giuseppe Console

Bone Marrow Transplant· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying and managing CAR T-cell-mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team.
Massimo Martino, Sebastiano Macheda, Umberto Aguglia, Luciano Arcudi, Giulia Pucci, Giuseppe Console

Expert Opin Biol Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival in a fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous stem cell transplant between 2000 and 2015: an EBMT registry-based study.
Massimo Martino, Annalisa Pitino, Mercedes Gori, Patrice Viens, Salvatore Siena, Giuseppe Console

Bone Marrow Transplant· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experience.
Barbara Loteta, Annalisa Paviglianiti, Virginia Naso, Anna Ferreri, Tiziana Moscato, Giuseppe Console

Support Care Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Burden in Caregivers of Multiple Myeloma Patients Undergoing Outpatient Autologous Stem-Cell Transplantation Compared to Inpatient Transplantation.
Massimo Martino, Annalisa Pitino, Giovanni Tripepi, Annalisa Paviglianiti, Letteria Russo, Giuseppe Console

Clin Lymphoma Myeloma Leuk· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granisetron transdermal system and dexamethasone for the prevention of nausea and vomiting in multiple myeloma patients receiving chemo-mobilization: An observational real-world study of effectiveness and safety.
Massimo Martino, Virginia Naso, Gaetana Porto, Annalisa Paviglianiti, Anna Ferreri, Giuseppe Console

Transfus Apher Sci· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy.
Jacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, Angelo Michele Carella, Massimo Martino, Giuseppe Console

Blood Adv· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case Report.
Cirino Botta, Nadia Caruso, Sabrina Bossio, Francesca Storino, Giuseppe Console

Front Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs.
Domenico Pastore, Benedetto Bruno, Paola Carluccio, Maria Stella De Candia, Sonia Mammoliti, Giuseppe Console

Ann Hematol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant.
Massimo Martino, Mercedes Gori, Giovanni Tripepi, Anna Grazia Recchia, Michele Cimminiello, Giuseppe Console

Ann Hematol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenge to Predict Mobilized Peripheral Blood Stem Cells on the Fourth Day of Granulocyte Colony-Stimulating Factor Treatment in Healthy Donors: Predictive Value of Basal CD34 Cell and Platelet Counts.
Massimo Martino, Mercedes Gori, Tiziana Moscato, Virginia Naso, Anna Ferreri, Giuseppe Console

Biol Blood Marrow Transplant· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials.
Massimo Martino, Marco Rossi, Anna Ferreri, Barbara Loteta, Antonella Morabito, Giuseppe Console

Expert Rev Hematol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model.
Massimo Martino, Sabino Ciavarella, Simona De Summa, Letteria Russo, Nicola Meliambro, Giuseppe Console

Biol Blood Marrow Transplant· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single step multiple genotyping by MALDI-TOF mass spectrometry, for evaluation of minor histocompatibility antigens in patients submitted to allogeneic stem cell transplantation from HLA-matched related and unrelated donor.
Federica Cattina, Simona Bernardi, Vilma Mantovani, Eleonora Toffoletti, Alessandra Santoro, Giuseppe Console

Hematol Rep· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous Stem Cell Transplantation in Patients With Multiple Myeloma: An Activity-based Costing Analysis, Comparing a Total Inpatient Model Versus an Early Discharge Model.
Massimo Martino, Giuseppe Console, Letteria Russo, Antonella Meliado', Nicola Meliambro

Clin Lymphoma Myeloma Leuk· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents.
Massimo Martino, Moreno Festuccia, Roberta Fedele, Giuseppe Console, Michele Cimminiello

Expert Opin Biol Ther· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for "De Novo" Multiple Myeloma Patients: A Phase II Study.
Maurizio Musso, Giuseppe Messina, Gianpaolo Marcacci, Alessandra Crescimanno, Giuseppe Console

Biol Blood Marrow Transplant· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobilization of hematopoietic stem cells with lenograstim in healthy donors: efficacy and safety analysis according to donor age.
Massimo Martino, Erminio Bonizzoni, Tiziana Moscato, Anna Grazia Recchia, Roberta Fedele, Giuseppe Console

Biol Blood Marrow Transplant· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A home-care, early discharge model after autografting in multiple myeloma: results of a three-arm prospective, non-randomized study.
Massimo Martino, Letteria Russo, Tiziana Martinello, Giuseppe Alberto Gallo, Roberta Fedele, Giuseppe Console

Leuk Lymphoma· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and efficacy of busulfan and fludarabine as allogeneic pretransplant conditioning therapy in acute myeloid leukemia: comparison with busulfan and cyclophosphamide regimen.
Roberta Fedele, Giuseppe Messina, Tiziana Martinello, Giuseppe Alberto Gallo, Antonella Pontari, Giuseppe Console

Clin Lymphoma Myeloma Leuk· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study.
Massimo Martino, Mauro Montanari, Felicetto Ferrara, Fabio Ciceri, Ilaria Scortechini, Giuseppe Console

Biol Blood Marrow Transplant· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.
Massimo Martino, Maurizio Postorino, Giuseppe Alberto Gallo, Giuseppe Messina, Santo Neri, Giuseppe Console

Clin Lymphoma Myeloma Leuk· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis